发明名称 COMPOUND FOR TREATING METABOLIC DISORDER
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a compound useful for treating various metabolic disorders such as insulin-resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, and arteriosclerosis. <P>SOLUTION: The compound is a medical agent, which is a biologically active agent, is represented by the following formula or is a pharmaceutically receptible salt of the above represented compound. In the formula, n is 1 or 2; m is 0 or 1; q is 0 or 1; t is 0 or 1; R<SP>9</SP>is hydrogen, halo-, or 1-3C alkoxy; and X is -CH<SB>2</SB>- and Q is -OR<SP>1</SP>, or X is -CH<SB>2</SB>CR<SP>12</SP>CR<SP>13</SP>- or CH<SB>2</SB>CH(NHAc)- and Q is OR<SP>1</SP>, or X is -CH<SB>2</SB>CH<SB>2</SB>- and Q is NR<SP>10</SP>R<SP>11</SP>. <P>COPYRIGHT: (C)2010,JPO&INPIT</p>
申请公布号 JP2009227690(A) 申请公布日期 2009.10.08
申请号 JP20090161269 申请日期 2009.07.07
申请人 WELLSTAT THERAPEUTICS CORP 发明人 SHARMA SHALINI;VON BORSTEL REID W;HODGE KIRVIN L;BAMAT MICHAEL K;WOLPE STEPHEN D
分类号 A61K31/00;C07C59/68;A61K31/16;A61K31/165;A61K31/192;A61K31/198;A61K31/216;A61K31/235;A61K31/27;A61K31/381;A61K31/41;A61K31/4196;A61K31/4402;A61K31/445;A61K31/535;A61K31/54;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P7/00;A61P9/10;A61P9/12;A61P13/12;A61P17/02;A61P25/00;A61P27/12;C07C51/09;C07C51/347;C07C51/41;C07C59/54;C07C59/90;C07C67/343;C07C69/738;C07C213/08;C07C217/22;C07C227/18;C07C229/36;C07C231/02;C07C231/12;C07C233/47;C07C235/34;C07C235/58;C07C235/78;C07C235/84;C07C237/32;C07C259/06;C07C319/20;C07C323/47;C07C323/52;C07C323/58;C07C323/59;C07C323/60;C07D213/30;C07D213/55;C07D249/10;C07D249/12;C07D257/04;C07D333/16;C07D333/22 主分类号 A61K31/00
代理机构 代理人
主权项
地址